NL
TMO icon

NWAM LLC’s Thermo Fisher Scientific TMO Stock Holding History

NWAM LLC’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.59M Sell
3,239
-269
-8% -$146K 0.09% 210
2025
Q4 		$2.19M Sell
3,508
-888
-20% -$502K 0.12% 170
2025
Q3 		$2.38M Buy
4,396
+634
+17% +$295K 0.13% 166
2025
Q2 		$1.75M Buy
+3,762
New +$1.57M 0.1% 193
2025
Q1 		– Sell
-4,667
Closed -$2.43M – 598
2024
Q4 		$2.43M Sell
4,667
-1,647
-26% -$906K 0.15% 147
2024
Q3 		$3.91M Buy
+6,314
New +$3.74M 0.24% 95
2024
Q2 		– Sell
-2,769
Closed -$1.59M – 497
2024
Q1 		$1.59M Sell
2,769
-12
-0.4% -$6.73K 0.13% 159
2023
Q4 		$1.48M Buy
2,781
+72
+3% +$34.9K 0.12% 171
2023
Q3 		$1.37M Sell
2,709
-535
-16% -$285K 0.14% 149
2023
Q2 		$1.69M Buy
3,244
+504
+18% +$272K 0.14% 145
2023
Q1 		$1.58M Buy
2,740
+48
+2% +$27.1K 0.16% 133
2022
Q4 		$1.48M Buy
2,692
+91
+3% +$48.2K 0.13% 166
2022
Q3 		$1.32M Sell
2,601
-1,341
-34% -$750K 0.13% 168
2022
Q2 		$2.15M Sell
3,942
-96
-2% -$52.8K 0.2% 107
2022
Q1 		$2.38M Buy
4,038
+599
+17% +$344K 0.18% 121
2021
Q4 		$2.29M Buy
3,439
+631
+22% +$394K 0.18% 128
2021
Q3 		$1.6M Buy
2,808
+1,388
+98% +$762K 0.15% 159
2021
Q2 		$716K Sell
1,420
-110
-7% -$51.9K 0.07% 251
2021
Q1 		$698K Buy
1,530
+1,007
+193% +$481K 0.07% 253
2020
Q4 		$244K Buy
+523
New +$245K 0.03% 387
2020
Q3 		– Sell
-1,687
Closed -$611K – 410
2020
Q2 		$611K Buy
1,687
+684
+68% +$229K 0.09% 214
2020
Q1 		$284 Buy
1,003
+195
+24% +$61.5K 0.01% 311
2019
Q4 		$262K Buy
+808
New +$245K 0.05% 328

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

NWAM LLC's TMO Position: Q1 2026 in Review

NWAM LLC reduced its Thermo Fisher Scientific (TMO) stake by 7.7% in Q1 2026, selling an estimated $146K and leaving 3,239 shares worth $1.59M. The position accounts for 0.09% of the portfolio, ranked #210.

NWAM LLC first reported a position in TMO in Q4 2019 and has held it in 23 quarters since. The position peaked at $3.91M in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • NWAM LLC held 3,239 shares of Thermo Fisher Scientific worth $1.59M as of Q1 2026.
  • NWAM LLC sold 269 Thermo Fisher Scientific shares in Q1 2026, an estimated $146K.
  • Thermo Fisher Scientific made up 0.09% of NWAM LLC's portfolio in Q1 2026, its #210 holding.
  • NWAM LLC first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 23 quarters since.
  • NWAM LLC's Thermo Fisher Scientific position peaked at $3.91M in Q3 2024.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on NWAM LLC's 13F filing for Q1 2026, filed 4 May 2026.